Which mushrooms have useful properties for colorectal cancer?
Through the selected fungi we intend a better response to conventional treatment and reduce the associated effects associated with these treatments.
The nutritional deficiencies of the oncological patient are a complex phenomenon, of multifactorial etiology and of important clinical consequences, which have an inseparable relationship with the severity of the disease.
By improving the nutritional status of the patient we improve their immune response and with it the risk of opportunistic infections and side effects.
There are data that justify the use of fungal extracts as a complement in chemotherapy treatments to reduce pain, cachexia and side effects (loss of hair and appetite, vomiting, etc.).
Patients treated with Reishi were more likely to respond positively to chemotherapy or radiation therapy compared to those who received only chemo or radiotherapy.
Oncological patients treated with Reishi show a considerable increase in the percentages of lymphocytes, an improvement in the quality of life and a reduction in side effects (nausea and insomnia) compared to the untreated ones.
Reishi contains biologically active compounds against the estrogen-mediated signaling system in tumor cells involved in this type of tumor.
The extract of Reishi has demonstrated sedative and anti-inflammatory capacity, as well as an increase in the total time of sleep, improving the quality of life.
The Mushroom extract of the sun produces improvements in appetite, alopecia, emotional stability and general weakness in gynecological patients undergoing chemotherapy.
The extract of Grifola frondosa is able to produce symptomatic improvements or regression of cancer in 68.8% of patients with breast cancer.
The extract of Coriolus versicolor (PSK) is able to improve the survival of patients with different types of cancer (mean 9% increase in overall survival and disease-free survival at 5 years) used in combination with chemotherapy against pharmacological treatment isolated.
Lion’s mane inhibits the growth of gastric, liver and colon cancer cell lines. In addition, it relieves abdominal pain and reduces precancerous cell growth and inflammation in patients with inflammatory bowel disease or chronic gastritis.
The bioactive polysaccharides present in the Seta of the present antiproliferative activity against gastric and colon cancer cell lines, as well as prebiotic activity.